reglab/statecodes huggingface dataset:
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 1 - GENERAL PROVISIONS › Section 8:63-1.3 - Publications and forms incorporated by reference

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The following publications and resources
				issued by the Centers for Disease Control and Prevention, Atlanta, GA, of the United
				States Department of Health and Human Services, are incorporated herein by
				reference, as amended and supplemented:
1.
				Integrated Prevention Services for HIV Infection, Viral Hepatitis, Sexually
				Transmitted Diseases, and Tuberculosis for Persons Who Use Drugs Illicitly: Summary
				Guidance, MMWR, Vol. 61, No. 5 (November 9, 2012), available at
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6105a1.htm
(hereinafter referred to as "CDC HIV Summary Guidance");
2. Data Security and Confidentiality Guidelines
				for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Programs:
				Standards to Facilitate Sharing and Use of Surveillance Data for Public Health
				Action (2011), available at
http://www.cdc.gov/nchhstp/programintegration/data-security.htm
,
				and at
http://www.cdc.gov/nchhstp/programintegration/docs/pcsidatasecurityguidelines.pdf
(hereinafter referred to as "CDC HIV Data Security and Confidentiality Guidelines");
				and
3. Updated Guidelines for
				Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other
				Nonoccupational Exposure to HIV--United States, 2016 (April 18, 2016, updated May
				23, 2018), available at
http://stacks.cdc.gov/view/cdc/38856
(hereinafter referred to as "CDC nPEP Guidelines").
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 2 - REGISTRATION › Section 8:63-2.1 - Application for registration

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An eligible entity
				shall apply to the Department for registration as a harm reduction center before
				providing authorized harm reduction services in the State.
(b) An eligible entity seeking to establish and
				operate a harm reduction center shall submit to the Division by electronic or
				regular mail:
1. A completed registration
				application in the form at chapter Appendix A; and
2. A data collection and program evaluation plan
				by which the harm reduction center will collect the following data elements, which
				are to be reported to the Department by means of a Department-designated data
				platform:
i. The number of unduplicated
				consumers;
ii. The number of syringes
				and needles dispensed;
iii. An estimate
				of the number of returned and disposed of syringes, provided that under no
				circumstances is a harm reduction center to require hand-counting of used
				syringes;
iv. The number of tests the
				harm reduction center performs for HIV, viral hepatitis, and sexually transmitted
				infections, if applicable, including the number of positive and negative
				results;
v. The number of referrals the
				harm reduction center issues for HIV, viral hepatitis, and sexually transmitted
				infection testing;
vi. The number of
				referrals to substance use disorder treatment services, and, if known, the number of
				consumers who enrolled or participated in substance use disorder treatment services
				following referral; and
vii. The number
				of referrals the harm reduction center issues for services other than testing and
				substance use disorder treatment.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 2 - REGISTRATION › Section 8:63-2.2 - Issuance and term of registration

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The Department shall
				review the application for completeness and compliance with the Act and this
				chapter.
(b) The Department shall issue
				a written determination to an applicant within 30 business days from the date it
				receives an application, in which it will:
1.
				Approve or deny the application in accordance with (c), (d), and (e)
				below;
2. Advise the applicant that the
				application is incomplete and specify the information or material needed to complete
				the application; or
3. Advise the
				applicant that the Department requires additional time within which to review the
				application and indicate the date by which the Department will provide a
				determination to approve or deny the application.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 2 - REGISTRATION › Section 8:63-2.3 - Renewal of registration

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The Department shall renew a registration to
				operate a harm reduction center, provided:
1. The
				harm reduction center submits to the Department, no fewer than 30 calendar days
				prior to the expiration of the existing registration, a fully and accurately
				completed form of application for renewal of its registration, containing the
				information listed in the form at chapter Appendix A;
2. The Department has not suspended or revoked the
				registration of the harm reduction center; and
3. The Department determines that the applicant
				remains in compliance with the requirements of the Act and this chapter.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 2 - REGISTRATION › Section 8:63-2.4 - Change of information notification requirements

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A harm
				reduction center seeking to relocate from the fixed location at which it registers
				to provide services shall apply for registration at the proposed new location in
				accordance with N.J.A.C. 8:63-2.1 and 2.2 and shall not
				provide services at the proposed new location until the Department approves
				registration of the harm reduction center at the proposed new location.
(b) A harm reduction center shall notify the
				Department, in writing, in care of the Division, at least 14 days before it plans to
				discontinue the provision of authorized harm reduction services in accordance with
				its registration application and/or supplements thereto.
(c) Subject to (a) and (b) above, a harm reduction
				center shall notify the Department, in writing, in care of the Division, no later
				than 14 calendar days after any change in the information on file with the
				Department in its registration application and/or supplements thereto, including
				hours of operation, services offered, or methods of service.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 3 - REQUIREMENTS FOR OPERATION OF A HARM REDUCTION CENTER › Section 8:63-3.1 - Harm reduction services provision; plans and protocols

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A harm reduction
				center shall provide authorized harm reduction services and harm reduction supplies
				to consumers at no cost, pursuant to its registration, in accordance with the Act
				and this chapter, and consistent with CDC HIV Summary Guidance.
(b) A harm reduction center shall establish and
				implement plans by which it will comply with each of the requirements at
				N.J.S.A.
				26:5C-28.b(1) through (10) and shall make these
				plans available to all harm reduction center personnel, and the Department, upon
				request.
(c) A harm reduction center
				shall establish and implement a plan for its compliance pursuant to
				N.J.S.A.
				26:5C-28.b(11) and shall submit the plan with its
				application for registration.
(d) A harm
				reduction center may obtain and distribute naloxone hydrochloride or another opioid
				antidote to family members and friends of consumers, and any member of the public in
				accordance with the Overdose Prevention Act,
				N.J.S.A.
				24:6J-1 et seq.
(e) A harm reduction center that authorizes
				consumers to engage in secondary distribution pursuant to the Act and this chapter
				shall maintain a policy for such secondary distribution, which may include a policy
				that authorizes all of the center's consumers to engage in secondary distribution in
				accordance with its policy. Except as otherwise provided in this section, nothing in
				this chapter shall be interpreted to restrict secondary distribution of harm
				reduction supplies, including syringes.
(f) A harm reduction center that contracts with a
				third-party entity pursuant to
				N.J.S.A.
				26:5C-28.a (1) need not obtain the Department's
				prior approval of the contract.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 3 - REQUIREMENTS FOR OPERATION OF A HARM REDUCTION CENTER › Section 8:63-3.2 - Provision of information

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A harm reduction
				center shall provide the following information to consumers:
1. A schedule of the harm reduction center's
				operating hours and locations; and
2.
				Spoken education about HIV, viral hepatitis, overdose prevention, harm reduction
				services, and substance use disorder treatment services, and, at the election of the
				harm reduction center, printed materials and links to electronic materials on these
				topics.
i. A list of trusted sources of
				information and material for distribution to consumers is available on the
				Division's website at
http://www.nj.gov/health/hivstdtb/hrc.shtml
.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 3 - REQUIREMENTS FOR OPERATION OF A HARM REDUCTION CENTER › Section 8:63-3.3 - Membership card

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A harm reduction
				center shall issue a Harm Reduction Center Membership Card in the form at chapter
				Appendix B to:
1. Consumers; and
2. Staff and volunteers of the harm reduction
				center.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 3 - REQUIREMENTS FOR OPERATION OF A HARM REDUCTION CENTER › Section 8:63-3.4 - Data collection, reporting, and evaluation

Current through Register Vol. 56, No. 14, July 15, 2024
(a) With
				respect to each consumer it serves, a harm reduction center shall collect and
				record, to the extent practicable and with the consumer's consent, at least the
				following information:
1. The consumer's age,
				race, ethnicity, sex at birth, and current gender identity;
2. The substances the consumer uses and the modes
				of use;
3. The dates on which the harm
				reduction center delivers authorized harm reduction services to the consumer;
				and
4. A list of the authorized harm
				reduction services and referrals, if any, that the harm reduction center provides
				during each encounter with a consumer.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 3 - REQUIREMENTS FOR OPERATION OF A HARM REDUCTION CENTER › Section 8:63-3.5 - Training, policies, and procedures

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A harm
				reduction center shall:
1. Ensure that staff and
				volunteers receive training as required at
				N.J.S.A.
				26:5C-28.b(2), and maintain records of staff and
				volunteer training;
2. Establish
				appropriate administrative, technical, and physical controls and safeguards that
				protect the confidentiality, integrity, and availability of individually
				identifiable information about consumers, in compliance with applicable provisions
				of the CDC HIV Data Security and Confidentiality Guidelines;
3. Establish procedures for compliance with the
				Bloodborne Pathogens Standard; and
4.
				Develop and maintain protocols for HIV post-exposure prophylaxis in accordance with
				guidelines of the Centers for Disease Control and Prevention available at
http://www.cdc.gov/hiv/risk/pep/index.html
.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 4 - ENFORCEMENT › Section 8:63-4.1 - Denial, suspension, or revocation of registration

Current through Register Vol. 56, No. 14, July 15, 2024
(a) If the
				Department determines that a registered harm reduction center is in violation of any
				provisions of the Act or this chapter, or if necessary to abate a threat to the
				public health, safety, or welfare, the Department may:
1. Issue a formal written warning; or
2. Suspend, revoke, or refuse to issue or renew, a
				registration to operate a harm reduction center.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 63 - HARM REDUCTION CENTERS › Subchapter 4 - ENFORCEMENT › Section 8:63-4.2 - Hearings on registration or enforcement actions

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An applicant or harm reduction center seeking
				a hearing pursuant to
				N.J.A.C.
				8:63-4.1(b)  shall submit to the
				Department a written request for a hearing within 30 calendar days from the date of
				the notice of denial, suspension, or revocation.
(b) Failure to submit a timely written request
				pursuant to (a) above shall result in the applicant or harm reduction center
				forfeiting all rights to such a hearing.
(c) Hearings shall be conducted pursuant to the
				Administrative Procedure Act,
				N.J.S.A.
				52:14B-1 et seq., and 52:14F-1 et seq., and the
				Uniform Administrative Procedure Rules, N.J.A.C. 1:1.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 1 - GENERAL PROVISIONS › Section 8:65-1.1 - Purpose and scope

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The purpose of this
				chapter is to establish standards for the reporting of cases of infection with Human
				Immunodeficiency Virus (HIV) to the Department pursuant to
				N.J.S.A. 26:1A-1 et seq.,
				especially 26:1A-7; 26:4-1 et seq., and 26:5C-1 et seq., particularly
				26:5C-6.
(b) This chapter applies to:
1. Health care providers and institutions that:
i. Order, or obtain the results of, HIV-related
				laboratory tests;
ii. Diagnose persons
				as having HIV infection; and/or
iii.
				Treat persons for HIV infection; and
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 1 - GENERAL PROVISIONS › Section 8:65-1.2 - Publications incorporated by reference

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The
				following web-based publications of, or administered by, the United States
				Department of Health and Human Services, are incorporated herein by reference, as
				amended and supplemented:
1. CDC, Revised
				Surveillance Case Definition for HIV Infection -- United States, 2014, MMWR 2014; 63
				(No. RR-3) (April 11, 2014) (hereinafter referred to as "surveillance case
				definition"), available at
http://www.cdc.gov/mmwr/pdf/rr/rr6303.pdf
,
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6303a1.htm
,
				and
http://www.cdc.gov/hiv/guidelines/reporting.html
;
2. CDC, Data Security and Confidentiality
				Guidelines for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis
				Programs: Standards to Facilitate Sharing and Use of Surveillance Data for Public
				Health Action (2011) (hereinafter referred to as the "Data Security Guidelines"),
				available at
http://www.cdc.gov/hiv/guidelines/reporting.html
and
http://www.cdc.gov/nchhstp/programintegration/docs/pcsidatasecurityguidelines.pdf
;
3. CDC, HIV Diagnostic Tests LOINC Map (2021),
				available at
http://www.cdc.gov/hiv/guidelines/reporting.html
;
4. CDC, National Center for Health Statistics,
				under authorization by the World Health Organization, International Statistical
				Classification of Diseases and Related Health Problems, 10th revision, Clinical
				Modification (2021 release) (hereinafter referred to as the "ICD-10-CM,") available
				at
http://www.cdc.gov/nchs/icd/icd10cm.htm
;
5. CDC and Association of Public Health
				Laboratories, Laboratory Testing for the Diagnosis of HIV Infection: Updated
				Recommendations (June 27, 2014) (hereinafter referred to as the "Laboratory Testing
				Recommendations"), available at
http://dx.doi.org/10.15620/cdc.23447
;
				and
6. CDC, 2018 Quick reference guide:
				Recommended laboratory HIV testing algorithm for serum or plasma specimens (2018)
				(hereinafter referred to as the "testing algorithm"), available at
http://stacks.cdc.gov/view/cdc/50872
.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 1 - GENERAL PROVISIONS › Section 8:65-1.4 - Forms and instructions

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The Department
				incorporates herein by reference the following forms and instructions for
				information collection, as amended and supplemented, promulgated by the National HIV
				Surveillance System of the CDC in accordance with procedures of the OIRA:
1. The information collection bearing OMB Control
				No. 0920-0573, particularly the following forms, and the instructions for completion
				thereof, which are available from the Department's forms page at
http://www.nj.gov/health/forms
or upon request to the Division:
i. Adult HIV
				Confidential Case Report Form (ACRF), CDC Form 50.42A (Revised November
				2019);
ii. The instructions for
				completion of the ACRF, entitled the Technical Guidance for HIV Surveillance
				Programs: Adult HIV Confidential Case Report Form (revised November 2019) (ACRF
				Technical Guidance);
iii. Pediatric HIV
				Confidential Case Report Form (PCRF), CDC Form 50.42B (revised November
				2019);
iv. Perinatal HIV Exposure
				Reporting Form (PHER), CDC Form 50.42D (revised November 2019); and
v. The instructions for completion of the PCRF and
				the PHER, entitled the Technical Guidance for HIV Surveillance Programs: Pediatric
				HIV Confidential Case Report Form and Perinatal HIV Exposure Reporting Form (PCRF
				and PHER Technical Guidance) (revised November 2019); and
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 2 - REPORTING HIV INFECTION DIAGNOSES AND HIV-RELATED LABORATORY TEST RESULTS › Section 8:65-2.1 - Health care providers to report, and responsible parties to ensure reporting of, HIV infection diagnoses and HIV-related laboratory test results in adults and adolescents

Current through Register Vol. 56, No. 14, July 15, 2024
(a) With respect to an
				adult and/or an adolescent who receives health care and/or resides in the State,
				health care providers shall complete all fields of an ACRF and submit it to the
				Division pursuant to N.J.A.C. 8:65-2.4within 24 hours of:
1. Obtaining an HIV-related laboratory test result
				performed on the adult or adolescent;
2.
				Making a diagnosis of a confirmed case of HIV infection in the adult or adolescent;
				and/or
3. Providing the adult or
				adolescent treatment for HIV infection.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 2 - REPORTING HIV INFECTION DIAGNOSES AND HIV-RELATED LABORATORY TEST RESULTS › Section 8:65-2.2 - Health care providers to report, and responsible parties to ensure reporting of, perinatal exposures to HIV, pediatric HIV-related laboratory test results, and pediatric HIV infection diagnoses in perinatal or pediatric cases

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A health care provider shall complete a PHER
				and a PCRF and submit them to the Division pursuant to N.J.A.C. 8:65-2.4within 24
				hours of identifying a patient as a case of perinatal exposure to HIV if:
1. The health care provider is providing health
				care to the patient in the State; and/or
2. The patient is a resident of the
				State.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 2 - REPORTING HIV INFECTION DIAGNOSES AND HIV-RELATED LABORATORY TEST RESULTS › Section 8:65-2.3 - Counseling and testing sites to report rapid HIV test results

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Within 24 hours of obtaining a positive rapid
				HIV test result for an adult or an adolescent, regardless of whether the adult or
				adolescent is a resident of the State, a counseling and testing site shall:
1. Submit information relating to the result in
				accordance with the content and procedural requirements of the information
				collection at OMB Control No. 0920-0696;
2. Submit within the information collection form
				the name, date of birth, and street address of the adult or adolescent;
				and
3. Specify the responses of the
				adult or adolescent to the following inquiries:
i.
				Whether the adult or adolescent had a previous negative HIV test result, and, if so,
				the date of the last test that yielded a negative result; and
ii. Whether the adult or adolescent had a previous
				positive HIV test result, and, if so, the date of the first test that yielded a
				positive result.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 2 - REPORTING HIV INFECTION DIAGNOSES AND HIV-RELATED LABORATORY TEST RESULTS › Section 8:65-2.4 - Procedure to report to the Division by health care providers, responsible parties, and counseling and testing sites

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Health care
				providers, responsible parties, and counseling and testing sites with reporting
				obligations pursuant to N.J.A.C. 8:65-2.1, 2.2, or 2.3 shall submit, or ensure
				submission of, required reports to the Division:
1.
				By postal mail marked "confidential," preferably using a Division envelope;
				or
2. By secure electronic facsimile
				(e-fax) to (609) 984-2455, subject to (b) below.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 2 - REPORTING HIV INFECTION DIAGNOSES AND HIV-RELATED LABORATORY TEST RESULTS › Section 8:65-2.5 - Clinical laboratories to report HIV-related laboratory test results

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A clinical laboratory director shall report to
				the Division the accession number, the CLIA code, and the following sections of the
				ACRF, in accordance with (b) below, within five working days of obtaining an
				HIV-related laboratory test result performed on a specimen taken from an adult or
				adolescent person who is receiving health care in, or is a resident of, the State:
1. The section labeled "Patient
				Identification";
2. The section labeled
				"Facility Providing Information";
3. The
				section labeled "Patient Demographics"; and
4. The section labeled "Laboratory
				Data."
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 2 - REPORTING HIV INFECTION DIAGNOSES AND HIV-RELATED LABORATORY TEST RESULTS › Section 8:65-2.6 - Mandatory content of laboratory order and specimen submission forms

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A health care provider that issues an order or
				submits a specimen to a clinical laboratory for HIV-related laboratory testing shall
				provide, and/or ensure the provision of, at least the following information in the
				order or specimen submission form:
1. The specimen
				collection date;
2. The health care
				provider's:
i. Name;
ii. Hospital, office, or practice name;
iii. Street address, municipality, zip code, and
				county; and
iv. Telephone number;
				and
3. The patient's:
i. Full name (first name, all middle names, and
				last name);
ii. Street address,
				municipality, zip code, and county;
iii.
				Telephone number;
iv. Sex assigned at
				birth and current gender identity;
v.
				Date of birth;
vi. The identifying
				number assigned to the patient by the health care provider ordering the laboratory
				test; and
vii. Pregnancy status, if
				applicable.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 3 - ACCESS TO RECORDS; ENFORCEMENT › Section 8:65-3.1 - Records subject to Department examination

Current through Register Vol. 56, No. 14, July 15, 2024
(a)
				Health care providers, responsible parties, and clinical laboratory directors shall
				make available to the Department on request, for inspection, audit, epidemiologic
				investigation, copying, scanning, and/or public health purposes, the complete health
				records, including identifying information, of:
1.
				Persons who have a confirmed diagnosis of HIV infection and who receive care or
				reside in the State;
2. Persons who
				receive care or reside in the State for whom an HIV-related laboratory test result
				is ordered or obtained;
3. Infants who
				have perinatal exposure; and
4. Women
				who give birth, and/or have given birth, to infants who have perinatal
				exposure.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 3 - ACCESS TO RECORDS; ENFORCEMENT › Section 8:65-3.2 - Access to information and records; confidentiality

Current through Register Vol. 56, No. 14, July 15, 2024
(a)
				Information, forms, and records submitted to or obtained by the Department pursuant
				to this chapter are not "government records" subject to public access or inspection
				within the meaning of
				N.J.S.A.
				47:1A-1 et seq., or under the common law,
				regardless of whether personal or other identifiers are removed or redacted, and are
				deemed to be:
1. "Information relating to medical .
				. . history, diagnosis, treatment, or evaluation" within the meaning of Executive
				Order 26, § 4(b)1 (McGreevey, August 13, 2002);
2. "Records concerning morbidity, mortality and
				reportable diseases of named individuals required to be made, maintained or kept by
				any State or local governmental agency" within the meaning of Executive Order 9,
				§ 2(c) (Hughes, September 30, 1963); and/or
3. Information "for use in the field of forensic
				pathology or for use in medical or scientific education or research" pursuant to
				N.J.S.A.
				47:1A-1.1.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 65 - HIV INFECTION REPORTING › Subchapter 3 - ACCESS TO RECORDS; ENFORCEMENT › Section 8:65-3.3 - Noncompliance with this chapter; enforcement; penalties

Current through Register Vol. 56, No. 14, July 15, 2024
(a) This chapter is part of the State Sanitary
				Code and persons who are noncompliant herewith are subject to the penalties for
				noncompliance with the State Sanitary Code at
				N.J.S.A.
				26:1A-10, and
				26:4-129
				and 130.
(b) Persons who are
				noncompliant with this chapter are subject to
				N.J.S.A.
				26:5C-14 and 18.
(c) In addition to other available actions and
				remedies:
1. Health care providers who are
				noncompliant with this chapter are subject to Department reporting of their
				noncompliance to applicable professional licensing boards with jurisdiction
				established pursuant to Title 45 of the Revised Statutes within the Division of
				Consumer Affairs of the New Jersey Department of Law and Public Safety, to
				credentialing and accrediting entities, health care facilities and other
				institutions at which they are employed or hold privileges, and health care plans
				and Federal payers from which they might seek compensation or reimbursement for
				health care services;
2. Responsible
				parties and/or institutions that are noncompliant with this chapter are subject to
				Department reporting of their noncompliance to credentialing and accrediting
				entities, Federal and State licensing entities with jurisdiction over the
				responsible party and/or the institution, and health care plans and Federal payers
				from which they might seek compensation or reimbursement for health care services;
				and
3. Clinical laboratory directors
				and/or clinical laboratories that are noncompliant with this chapter are subject to
				Department reporting of their noncompliance to credentialing and accrediting
				entities, Federal and State clinical laboratory director and clinical laboratory
				licensing authorities with jurisdiction, health care facilities and other
				institutions at which they are employed, hold privileges, or provide services, and
				health care plans and Federal payers from which they might seek compensation or
				reimbursement for health care services.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 67 - EXPEDITED PARTNER THERAPY › Subchapter 1 - GENERAL PROVISIONS › Section 8:67-1.1 - Purpose and scope

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The purpose of this
				chapter is to implement expedited partner therapy in the State, in accordance with
				P.L. 2019, c. 336, an act concerning treatment of sexually transmitted diseases and
				supplementing Title 26 of the Revised Statutes (effective May 1, 2020) (Act),
				codified at N.J.S.A. 26:4-48.2 through 48.4.
(b) This chapter applies to health care
				professionals in the State who elect to provide expedited partner therapy.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 67 - EXPEDITED PARTNER THERAPY › Subchapter 1 - GENERAL PROVISIONS › Section 8:67-1.2 - Definitions

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The following words
				and terms, as used in this chapter, have the meanings that N.J.S.A. 26:448.2
				establishes:
1. "Commissioner";
2. "Department";
3. "Expedited partner therapy"; and
4. "Health care professional."
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 67 - EXPEDITED PARTNER THERAPY › Subchapter 1 - GENERAL PROVISIONS › Section 8:67-1.3 - Publications incorporated by reference

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The
				following publication of the CDC is incorporated herein by reference, as amended and
				supplemented:
1. Workowski KA, Bochman LH, Chan
				PA, et al, and CDC,
Sexually Transmitted Infections Treatment Guidelines,
				2021
. MMWR Recomm Rep 2021; 70 (No. RR-43): 1-187 (July 23, 2021),
				available at
http://www.cdc.gov/std/default.htm
(hereinafter referred to as "STI Treatment Guidelines").
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 67 - EXPEDITED PARTNER THERAPY › Subchapter 1 - GENERAL PROVISIONS › Section 8:67-1.4 - Informational material

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The STD Program
				shall post to its website the informational material it develops pursuant to
				N.J.S.A. 26:4-48.3, for distribution by health care professionals to each patient
				whom the health care professional diagnoses as having a sexually transmitted disease
				and for whom the professional elects to provide EPT for subsequent delivery by the
				patient to all of the patient's sexual partners who are eligible for expedited
				partner therapy (DOH EPT informational material).
(b) The Department shall:
1. Distribute free copies of the DOH EPT
				informational material throughout the State at conferences, trainings, and other
				professional gatherings of health care professionals; and
2. Make available copies of the DOH EPT
				informational material to health care professionals upon telephone request to the
				STD Program.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 67 - EXPEDITED PARTNER THERAPY › Subchapter 1 - GENERAL PROVISIONS › Section 8:67-1.5 - Expedited partner therapy guidance material for health care professionals pursuant to N.J.S.A. 26:4-48.3

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The STD Program
				shall post to its website, the guidance material it develops pursuant to N.J.S.A.
				26:4-48.3 to guide health care professionals in the provision of EPT (DOH EPT
				guidance for health care professionals).
(b) The Department shall:
1. Distribute free copies of the DOH EPT guidance
				for health care professionals throughout the State at conferences, trainings, and
				other professional gatherings of health care professionals; and
2. Make available copies of the DOH EPT
				informational material to health care professionals upon telephone request to the
				STD Program.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 67 - EXPEDITED PARTNER THERAPY › Subchapter 2 - PROVISION OF EXPEDITED PARTNER THERAPY › Section 8:67-2.1 - STIs for which provision of EPT is indicated

Current through Register Vol. 56, No. 14, July 15, 2024
(a)
				Pursuant to N.J.S.A. 26:4-48, the Department identifies EPT to be indicated for the
				STIs for which the STI Treatment Guidelines identify EPT to be indicated.
(b) In prescribing EPT, a health care professional
				shall adhere to the STI Treatment Guidelines, particularly with respect to the STIs
				for which the STI Treatment Guidelines state that EPT is indicated, and the
				corresponding treatments.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 67 - EXPEDITED PARTNER THERAPY › Subchapter 2 - PROVISION OF EXPEDITED PARTNER THERAPY › Section 8:67-2.2 - Distribution of DOH informational material

Current through Register Vol. 56, No. 14, July 15, 2024
When a health care professional issues EPT, the health care
				  professional shall give the patient a sufficient number of copies, depending on the
				  number of partners a patient identifies, of the DOH EPT informational material, with
				  instructions to the patient to give the DOH EPT informational material that is for
				  partners to the patient's partners.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 1 - AUTOPSIES › Section 8:70-1.1 - Mandatory autopsies

Current through Register Vol. 56, No. 14, July 15, 2024
(a) In the absence of an
				objection based on the religious beliefs of the decedent, autopsies shall be
				performed in all cases of human death occurring in the following circumstances;
				however, the autopsy should be the least intrusive procedure consistent with proper
				forensic practice (as defined in N.J.A.C. 8:70-1.8) and the duty to preserve organs
				for transplant:
1. All cases of apparent homicidal
				deaths;
2. All deaths occurring under
				suspicious or unusual circumstances;
3.
				All deaths from causes which might constitute a threat to public health;
4. All deaths of inmates of jail, prison, or
				penitentiary and all prisoners and suspects who were in the process of being
				detained, arrested or transported by guards, police and law enforcement or court
				officers unless the suspected cause of death is a known condition for which the
				inmate, prisoner or suspect is hospitalized and being treated at the time of death,
				and the medical examiner's investigation, review of hospital records, and
				examination of the decedent's body permit him or her to determine the cause of death
				beyond a reasonable doubt without an autopsy, and no other issues of public interest
				compel his or her conclusion that an autopsy is necessary;
5. All infants and children suspected of having
				been abused or neglected and children suspected of having died from sudden infant
				death syndrome (SIDS);
6. In all cases
				wherein the State Medical Examiner, the Attorney General, any assignment judge of
				the Superior Court, or the county prosecutor (of the county wherein the injury
				occurred or where the decedent expired) requests an autopsy;
7. In all cases otherwise under the Medical
				Examiner's jurisdiction where the decedent has been identified as a potential donor
				pursuant to P.L. 1969, c.161 (N.J.S.A.
				26:6-57 et seq.), the medical examiner shall
				perform any necessary examination, autopsy or analysis of any organ or tissue in a
				manner and within a time period compatible with preservation of the organ or tissue
				for the purpose of transplantation.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 1 - AUTOPSIES › Section 8:70-1.2 - Discretionary autopsies

Current through Register Vol. 56, No. 14, July 15, 2024
(a) In the absence of an
				objection based on the religious beliefs of the decedent, autopsies may be performed
				when it appears in the discretion of the county medical examiner to be in the public
				interest to do so in all cases of human deaths occurring in the following
				circumstances:
1. All cases of violent deaths
				which are apparently suicidal or accidental, including but not limited to deaths due
				to thermal, chemical, electrical or radiation injury, except as enumerated in
				N.J.A.C. 8:70-1.1, Mandatory autopsies;
2. All deaths caused by disease, disability or
				infirmity which are not readily recognizable;
3. All deaths of inmates as defined in N.J.S.A.
				52:17B-86(f)occurring in institutions maintained in whole or in part at the expense
				of the State or county when the inmate was not hospitalized therein for organic
				disease;
4. All deaths related to
				diseases resulting from employment or from accidents while employed;
5. All deaths from motor vehicle collisions to
				include drivers, occupants, and pedestrians.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 1 - AUTOPSIES › Section 8:70-1.3 - Jurisdiction between counties

Current through Register Vol. 56, No. 14, July 15, 2024
(a) When the
				medical examiner of the county wherein the death occurred determines that the
				incident which is suspected of being the cause of death has occurred in a New Jersey
				county other than his or her own, he or she may transfer jurisdiction to that county
				medical examiner immediately for the continuance of the investigation. Any county
				medical examiner to whom jurisdiction is transferred pursuant to this section shall
				immediately take charge of the continuance of the investigation and shall perform
				any examinations, autopsies or other functions required by the State Medical
				Examiner Act.
(b) Whenever any county
				medical examiner office has been notified of a death, that office shall take the
				name and address of the decedent if known, the time of notification, time of death,
				time of onset of illness or injury if known, or time found, and the name and station
				of the person reporting the death.
1. He or she
				shall then determine jurisdiction, and either report the death properly to the
				medical examiner of the county wherein the death occurred if necessary; or retain
				jurisdiction and complete the investigation if applicable; or transfer jurisdiction
				if required.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 1 - AUTOPSIES › Section 8:70-1.4 - Armed forces aircraft victims

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Because of
				mandatory regulations of the United States Armed Services concerning autopsies of
				military personnel killed in military aircraft accidents and the procedure for such
				examinations, it is desirable that autopsies in such cases be performed where
				feasible by pathologists who are members of or employed by the armed
				services.
(b) The county medical
				examiner, or such other person designated or approved by the State Medical Examiner
				to perform autopsies, is therefore authorized to allow transportation of bodies of
				armed forces personnel killed in military aircraft accidents in territory which is
				within the county's jurisdiction to facilities designated by either the Surgeon
				General or other authorized member of the United States military services for such
				autopsy.
(c) The county medical examiner
				shall endeavor to obtain a copy of the report of the findings of such autopsy from
				the military officer in charge of same in order that a proper death certificate may
				be issued.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 1 - AUTOPSIES › Section 8:70-1.5 - Medical examiner autopsies

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Medical examiner
				autopsies shall be performed only in conjunction with investigations of reportable
				deaths in order to establish the cause of death; to provide medical facts upon which
				to base a determination of the manner of death; to collect evidence and medical
				specimens and documentation with probative value; to clarify investigation
				information, or to serve the needs of public health and safety and of the
				courts.
(b) Medical examiner autopsies
				shall not be performed solely to satisfy the academic interest of a hospital or
				medical staff, or to circumvent the lack of family permission for hospital
				autopsy.
(c) In the case of potential
				organ donors as defined by P.L. 1969, c.161 (N.J.S.A.
				26:6-57 et seq.), the medical examiner shall
				perform the least intrusive procedure consistent with proper forensic practice and
				the duty to preserve organs for transplant in a manner and within a time period
				compatible with the preservation of the organ or tissue for the purpose of
				transplantation.
(d) Except as provided
				in (c) above, the autopsy standard for apparent homicides, suicides, suspicious
				deaths, and deaths with no visible anatomic cause shall include a complete
				inspection, removal and dissection of the cranial compartment and contents, the neck
				viscera and tongue, the thoracic, abdominal and pelvic compartments and viscera, and
				any additional dissections which may be indicated by the circumstances of death; and
				shall include the collection and preservation of body tissues for toxicological and
				microscopic examination and any additional examinations which may be required by the
				nature of the circumstances.
(e) X-ray
				examination of the whole body shall be performed in all instances where child abuse
				or neglect is a possibility and in the investigation of human skeletal remains.
				X-ray examination shall also be undertaken in all gunshot injuries where indicated
				for complete recovery of evidence, and in conjunction with examination and
				identification of human bodies in an advanced state of decomposition, or
				unrecognizable bodies.
(f) No person,
				technician, or aide shall perform any part of the postmortem dissection of the body,
				without the direct and immediate supervision and observation of the medical examiner
				or designated pathologist and then, only after proper training and
				guidance.
(g) Except as provided in (c)
				above, microscopic examination shall be conducted in the following circumstances:
1. In all cases of infant death;
2. Whenever an autopsy including toxicological
				testing fails to disclose a cause of death;
3. When the age of an injury requires further
				evaluation;
4. Whenever indicated by the
				circumstances of the death; and
5.
				Whenever else it is deemed necessary at the discretion of the medical
				examiner.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 1 - AUTOPSIES › Section 8:70-1.7 - Medical examiner's investigative standards for unidentified decedents

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A decedent is to be regarded as "unidentified"
				when, at the time of initial discovery and investigation:
1. The body is visually recognizable but there is
				no circumstantial indication of the decedent's full name either by personal effects
				on the body or by personal acquaintance of those present at the scene of discovery;
				or
2. The body is not visually
				recognizable due to alteration of physical features and there is no obvious reason
				to suspect a tentative identity for the decedent.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 1 - AUTOPSIES › Section 8:70-1.8 - Definitions

Current through Register Vol. 56, No. 14, July 15, 2024
The following words and terms, as used in this subchapter, shall
				  have the following meanings:
"Involved in the cause of death": an organ is involved in the
				  cause of death when disruption to that organ's structure is a required element of
				  the fatal sequence and/or provides the means of diagnosing the cause of
				  death.
"Proper forensic practice" consists of those procedures which are
				  required to perform the mandated role of medical examiner, which is to determine the
				  cause and manner of death within a reasonable degree of medical probability; to
				  identify and analyze evidence in criminal matters; to preserve organs for transplant
				  and to otherwise preserve the public health.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 2 - SPECIMEN COLLECTION › Section 8:70-2.1 - Collection of specimens for alcohol determinations

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Whenever the county medical examiner, or the
				person designated by the State Medical Examiner or county medical examiner to
				conduct investigations and perform autopsies in a county, conducts an autopsy
				pursuant to N.J.S.A. 52:17B-88et seq., that person shall collect suitable specimens
				for determination of the alcohol content of the blood and brain tissue in all cases
				of violent death or death under unusual circumstances where death has occurred
				within 48 hours of the incident suspected of being the proximate cause of
				death.
(b) Said samples shall be
				properly labeled, refrigerated, and submitted within two weeks to the New Jersey
				State Medical Examiner Toxicology Laboratory for the required analysis.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 2 - SPECIMEN COLLECTION › Section 8:70-2.2 - Collection of specimens for narcotic or dangerous drug determination

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Whenever the county
				medical examiner, or the person designated by the State Medical Examiner or county
				medical examiner to conduct the investigations and perform autopsies in a county,
				conducts an autopsy pursuant to N.J.S.A. 52:17B-88et seq., that person shall collect
				suitable specimens for determination of the drug content of the body fluids and
				tissues in all cases of violent deaths or deaths under unusual circumstances where
				death has occurred within 48 hours of the incident suspected of being the proximate
				cause of death.
(b) Said samples shall
				be properly labeled, refrigerated, and submitted within two weeks to the New Jersey
				State Medical Examiner Toxicology Laboratory for the required analysis.
New Jersey Administrative Code › Title 8 - HEALTH › Chapter 70 - CHIEF STATE MEDICAL EXAMINER RULES › Subchapter 2 - SPECIMEN COLLECTION › Section 8:70-2.3 - Specimens for microscopic examination

Current through Register Vol. 56, No. 14, July 15, 2024
Specimens from the vital organs and sites of fatal injury shall be
				  retained in a suitable preservative such as formalin solution on every autopsy
				  conducted by the medical examiners, labeled by name and case number. These shall be
				  retained for 10 years unless histologic slides have been prepared and
				  examined.